Annual revenue:
$37.31M-$333.89M(-89.95%)Summary
- As of today (September 11, 2025), CRSP annual revenue is $37.31 million, with the most recent change of -$333.89 million (-89.95%) on December 31, 2024.
- During the last 3 years, CRSP annual revenue has fallen by -$877.65 million (-95.92%).
- CRSP annual revenue is now -95.92% below its all-time high of $914.96 million, reached on December 31, 2021.
Performance
CRSP Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$892.00K+$27.00K(+3.12%)Summary
- As of today (September 11, 2025), CRSP quarterly revenue is $892.00 thousand, with the most recent change of +$27.00 thousand (+3.12%) on June 30, 2025.
- Over the past year, CRSP quarterly revenue has increased by +$375.00 thousand (+72.53%).
- CRSP quarterly revenue is now -99.90% below its all-time high of $900.70 million, reached on June 30, 2021.
Performance
CRSP Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$38.05M+$375.00K(+1.00%)Summary
- As of today (September 11, 2025), CRSP TTM revenue is $38.05 million, with the most recent change of +$375.00 thousand (+1.00%) on June 30, 2025.
- Over the past year, CRSP TTM revenue has dropped by -$164.18 million (-81.18%).
- CRSP TTM revenue is now -95.84% below its all-time high of $915.36 million, reached on March 31, 2022.
Performance
CRSP TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CRSP Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -90.0% | +72.5% | -81.2% |
| 3 y3 years | -95.9% | +464.6% | +156.7% |
| 5 y5 years | -87.1% | +1927.3% | -86.8% |
CRSP Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -95.9% | +3014.7% | -99.6% | >+9999.0% | -89.8% | +3076.1% |
| 5 y | 5-year | -95.9% | +5089.7% | -99.9% | >+9999.0% | -95.8% | +5192.1% |
| alltime | all time | -95.9% | >+9999.0% | -99.9% | >+9999.0% | -95.8% | >+9999.0% |
CRSP Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $892.00K(+3.1%) | $38.05M(+1.0%) |
| Mar 2025 | - | $865.00K(-97.6%) | $37.67M(+1.0%) |
| Dec 2024 | $37.31M(-89.9%) | $35.69M(+5828.7%) | $37.31M(-81.6%) |
| Sep 2024 | - | $602.00K(+16.4%) | $202.83M(+0.3%) |
| Jun 2024 | - | $517.00K(+2.6%) | $202.23M(-25.6%) |
| Mar 2024 | - | $504.00K(-99.7%) | $271.71M(-26.8%) |
| Dec 2023 | $371.21M(>+9900.0%) | $201.21M(>+9900.0%) | $371.21M(+118.3%) |
| Sep 2023 | - | $0.00(-100.0%) | $170.01M(-0.1%) |
| Jun 2023 | - | $70.00M(-30.0%) | $170.10M(+69.7%) |
| Mar 2023 | - | $100.00M(>+9900.0%) | $100.26M(+8268.8%) |
| Dec 2022 | $1.20M(-99.9%) | $6000.00(-93.6%) | $1.20M(-91.5%) |
| Sep 2022 | - | $94.00K(-40.5%) | $14.09M(-4.9%) |
| Jun 2022 | - | $158.00K(-83.2%) | $14.82M(-98.4%) |
| Mar 2022 | - | $940.00K(-92.7%) | $915.36M(+0.0%) |
| Dec 2021 | $914.96M(>+9900.0%) | $12.90M(+1465.4%) | $914.96M(+1.4%) |
| Sep 2021 | - | $824.00K(-99.9%) | $902.43M(+0.1%) |
| Jun 2021 | - | $900.70M(>+9900.0%) | $901.76M(>+9900.0%) |
| Mar 2021 | - | $539.00K(+45.7%) | $1.10M(+53.1%) |
| Dec 2020 | $719.00K | $370.00K(+150.0%) | $719.00K(-99.1%) |
| Sep 2020 | - | $148.00K(+236.4%) | $77.36M(-73.2%) |
| Jun 2020 | - | $44.00K(-72.0%) | $289.14M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $157.00K(-99.8%) | $289.42M(-0.1%) |
| Dec 2019 | $289.59M(+9169.8%) | $77.02M(-63.7%) | $289.59M(+36.2%) |
| Sep 2019 | - | $211.93M(>+9900.0%) | $212.69M(>+9900.0%) |
| Jun 2019 | - | $318.00K(-3.0%) | $1.32M(-36.8%) |
| Mar 2019 | - | $328.00K(+185.2%) | $2.09M(-33.0%) |
| Dec 2018 | $3.12M(-92.4%) | $115.00K(-79.6%) | $3.12M(-91.2%) |
| Sep 2018 | - | $563.00K(-48.3%) | $35.33M(-4.9%) |
| Jun 2018 | - | $1.09M(-19.9%) | $37.16M(-6.3%) |
| Mar 2018 | - | $1.36M(-95.8%) | $39.65M(-3.3%) |
| Dec 2017 | $41.00M(+693.9%) | $32.33M(+1254.2%) | $41.00M(+272.2%) |
| Sep 2017 | - | $2.39M(-33.4%) | $11.02M(+8.2%) |
| Jun 2017 | - | $3.58M(+32.5%) | $10.18M(+37.7%) |
| Mar 2017 | - | $2.70M(+15.3%) | $7.39M(+43.1%) |
| Dec 2016 | $5.16M(+1990.7%) | $2.34M(+51.3%) | $5.16M(+83.1%) |
| Sep 2016 | - | $1.55M(+94.8%) | $2.82M(+121.9%) |
| Jun 2016 | - | $795.00K(+67.0%) | $1.27M(+167.0%) |
| Mar 2016 | - | $476.00K(>+9900.0%) | $476.00K(>+9900.0%) |
| Dec 2015 | $247.00K(>+9900.0%) | - | - |
| Jun 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00 | $0.00 |
| Dec 2014 | $0.00 | - | - |
FAQ
- What is CRISPR Therapeutics AG annual revenue?
- What is the all time high annual revenue for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual revenue year-on-year change?
- What is CRISPR Therapeutics AG quarterly revenue?
- What is the all time high quarterly revenue for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly revenue year-on-year change?
- What is CRISPR Therapeutics AG TTM revenue?
- What is the all time high TTM revenue for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM revenue year-on-year change?
What is CRISPR Therapeutics AG annual revenue?
The current annual revenue of CRSP is $37.31M
What is the all time high annual revenue for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual revenue is $914.96M
What is CRISPR Therapeutics AG annual revenue year-on-year change?
Over the past year, CRSP annual revenue has changed by -$333.89M (-89.95%)
What is CRISPR Therapeutics AG quarterly revenue?
The current quarterly revenue of CRSP is $892.00K
What is the all time high quarterly revenue for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly revenue is $900.70M
What is CRISPR Therapeutics AG quarterly revenue year-on-year change?
Over the past year, CRSP quarterly revenue has changed by +$375.00K (+72.53%)
What is CRISPR Therapeutics AG TTM revenue?
The current TTM revenue of CRSP is $38.05M
What is the all time high TTM revenue for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM revenue is $915.36M
What is CRISPR Therapeutics AG TTM revenue year-on-year change?
Over the past year, CRSP TTM revenue has changed by -$164.18M (-81.18%)